Scott Fields

About the Author Scott Fields

A media and finance professional with four years experience at Australia’s largest business newspaper: As a journalist, I have covered major economic and financial events, in depth and in a timely manner, building strong relationships with senior executive. I am twice the recipient of Citigroup’s Journalism Award for Excellence in Financial Markets coverage. Prior to my current role I held the role of senior editor at a capital markets publication and worked on the bond syndicate desk at a major bank.

Aspen Technology: This Is A Reasonably Compelling Entry Point, Says Canaccord

In a research note issued August 22, Canaccord analyst Richard Davis maintained a Buy rating on Aspen Technology (NASDAQ: AZPN), followoing the last week’s 7% post fourth-quarter sell off. …

Wedbush Reiterates Underperform On Regado Following 2Q14 Financials Release

Analyst Liana Moussatos of Wedbush yesterday reiterated an Underperform rating on Regado Biosciences (NASDAQ:RGDO), with a $2 price target, after the company released its second-quarter financials.  Moussatos notes: …

William Blair Maintains Underperform On Target Following 2Q14 Results

Yesterdays, analyst Mark Miller of William Blair published a report in which he maintained an Underperform rating on Target Corp. (NYSE:TGT) stock.

William Blair Maintains Buy On Cornerstone Following Meeting With Management

William Blair Analysts met with the Management of Cornerstone OnDemand (NASDAQ:CSOD) to discuss financials and the future of the company. In result of …

Wedbush Reiterates Outperform On Pacira Following Stronger-Than-Expected July Estimates For EXPAREL

In a report issued yesterday, analyst Liana Moussatos of Wedbush reiterated an Outperform rating on Pacira Pharmaceuticals (NASDAQ:PCRX) with a $110 price target, following strong July Symphony Health …

Roth Capital Reiterates Buy On Cytori After Receving Funding From BARDA

Cytori Therapeutics (NASDAQ:CYTX) announced that BARDA executed the option to fund the continued development of Cytori Cell Therapy for thermal burn injuries. The current …

General Electric Share Price Looks Cheap, Says Credit Suisse

In a report published on today, Credit Suisse analyst Julian Mitchell reinstated coverage on General Electric (NYSE:GE) with an Outperform rating and a $30 target price, which …

Deutsche Bank Maintains Buy On Tesla Following Expansion Of Model S Warranty

In a research note issued today, Deutsche Bank analyst Rod Lache maintained a Buy rating on Tesla Motors (NASDAQ:TLSA) with a $310 price target, following the …

Piper Jaffray Maintains Overweight On eBay Following ChannelAdvisor Report

In a report published on August 13th, 2014 Piper Jaffray analyst Gene Munster maintained an Overweight rating on eBay Inc. (NASDAQ:EBAY) with a price …

GT Advanced: Too Many “What-Ifs” Keep Us On The Sideline, Says UBS

In a research note published today, UBS analyst Stephen Chin maintained a Neutral rating on GT Advanced Technologies (NASDAQ:GTAT) following the company’s second-quarter results, and lowered his price target to …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts